A role for PPARα in the medial prefrontal cortex in formalin-evoked nociceptive responding in rats

British Journal of Pharmacology

Volumn 171, Issue 6, 2014, Pages 1462-1471

  Okine, B N ^a   Rea, K ^a   Olango, W M ^a   Price, J ^a   Herdman, S ^a   Madasu, M K ^a   Roche, M ^a   Finn, D P ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

formalin test; GW6471; GW7647; medial prefrontal cortex; N oleoylethanolamide; N palmitoylethanolamide; pain; PPAR ; Sprague Dawley rats

Indexed keywords

CANNABINOID 1 RECEPTOR; MESSENGER RNA; N OLEOYLETHANOLAMINE; PALMIDROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FORMALIN TEST; GENE EXPRESSION; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NOCICEPTION; NONHUMAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA GENE; PHARMACOLOGICAL BLOCKING; PHARMACOLOGICAL STIMULATION; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

FORMALIN TEST; GW6471; GW7647; MEDIAL PREFRONTAL CORTEX; N-OLEOYLETHANOLAMIDE; N-PALMITOYLETHANOLAMIDE; PAIN; PPARΑ; SPRAGUE-DAWLEY RATS;

ANIMALS; FORMALDEHYDE; MALE; PAIN; PPAR ALPHA; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84895767901     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12540     Document Type: Article

References (46)

1. Benani A, Heurtaux T, Netter P, Minn A, (2004). Activation of peroxisome proliferator-activated receptor alpha in rat spinal cord after peripheral noxious stimulation. Neurosci Lett 369: 59-63. (Pubitemid 39369503)
2. Bradford MM, (1976). Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Anal Biochem 72: 248-254.
3. Braissant O, Foufelle F, Scotto C, Dauca M, Wahli W, (1996). Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology 137: 354-366. (Pubitemid 26005011)
4. Calignano A, La Rana G, Piomelli D, (2001). Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. Eur J Pharmacol 419: 191-198. (Pubitemid 32568218)
5. Chinetti G, Fruchart JC, Staels B, (2003). Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applications. Int J Obes Relat Metab Disord 27 (Suppl 3): S41-S45. (Pubitemid 38019187)
6. Crisafulli C, Cuzzocrea S, (2009). The role of endogenous and exogenous ligands for the peroxisome proliferator-activated receptor alpha (PPAR-alpha) in the regulation of inflammation in macrophages. Shock 32: 62-73.
7. Cuzzocrea S, Bruscoli S, Mazzon E, Crisafulli C, Donato V, Paola DI, et al. (2008). Peroxisome proliferator-activated receptor-alpha contributes to the anti-inflammatory activity of glucocorticoids. Mol Pharmacol 73: 323-337. (Pubitemid 351181185)
8. D'agostino G, La Rana G, Russo R, Sasso O, Iacono A, Esposito E, et al. (2007). Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice. J Pharmacol Exp Ther 322: 1137-1143. (Pubitemid 47295805)
9. D'agostino G, La Rana G, Russo R, Sasso O, Iacono A, Esposito E, et al. (2009). Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia. Eur J Pharmacol 613: 54-59.
10. De Novellis V, Luongo L, Guida F, Cristino L, Palazzo E, Russo R, et al. (2012). Effects of intra-ventrolateral periaqueductal grey palmitoylethanolamide on thermoceptive threshold and rostral ventromedial medulla cell activity. Eur J Pharmacol 676: 41-50.
11. Delerive P, Fruchart JC, Staels B, (2001). Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol 169: 453-459. (Pubitemid 32536978)
12. Desvergne B, Wahli W, (1999). Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20: 649-688. (Pubitemid 30650602)
13. Duncan NW, Wiebking C, Tiret B, Marjanska M, Hayes DJ, Lyttleton O, et al. (2013). Glutamate concentration in the medial prefrontal cortex predicts resting-state cortical-subcortical functional connectivity in humans. PLoS ONE 8: e60312.
14. Etkin A, Egner T, Kalisch R, (2010). Emotional processing in anterior cingulate and medial prefrontal cortex. Trends Cogn Sci 15: 85-93.
15. Finn DP, Jhaveri MD, Beckett SR, Roe CH, Kendall DA, Marsden CA, et al. (2003). Effects of direct periaqueductal grey administration of a cannabinoid receptor agonist on nociceptive and aversive responses in rats. Neuropharmacology 45: 594-604. (Pubitemid 36980816)
16. Ford GK, Moriarty O, McGuire BE, Finn DP, (2008). Investigating the effects of distracting stimuli on nociceptive behaviour and associated alterations in brain monoamines in rats. Eur J Pain 12: 970-979.
17. Fu J, Astarita G, Gaetani S, Kim J, Cravatt BF, Mackie K, et al. (2007). Food intake regulates oleoylethanolamide formation and degradation in the proximal small intestine. J Biol Chem 282: 1518-1528. (Pubitemid 47076553)
18. Giordano C, Cristino L, Luongo L, Siniscalco D, Petrosino S, Piscitelli F, et al. (2011). TRPV1-dependent and -independent alterations in the limbic cortex of neuropathic mice: impact on glial caspases and pain perception. Cereb Cortex 22: 2495-2518.
19. Gofflot F, Chartoire N, Vasseur L, Heikkinen S, Dembele D, Le Merrer J, et al. (2007). Systematic gene expression mapping clusters nuclear receptors according to their function in the brain. Cell 131: 405-418. (Pubitemid 47576140)
20. Hadjipavlou G, Dunckley P, Behrens TE, Tracey I, (2006). Determining anatomical connectivities between cortical and brainstem pain processing regions in humans: a diffusion tensor imaging study in healthy controls. Pain 123: 169-178. (Pubitemid 43816770)
21. Jasmin L, Granato A, Ohara PT, (2004). Rostral agranular insular cortex and pain areas of the central nervous system: a tract-tracing study in the rat. J Comp Neurol 468: 425-440. (Pubitemid 37549660)
22. Jhaveri MD, Richardson D, Robinson I, Garle MJ, Patel A, Sun Y, et al. (2008). Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory pain. Neuropharmacology 55: 85-93.
23. Kerr DM, Burke NN, Ford GK, Connor TJ, Harhen B, Egan LJ, et al. (2012). Pharmacological inhibition of endocannabinoid degradation modulates the expression of inflammatory mediators in the hypothalamus following an immunological stressor. Neuroscience 204: 53-63.
24. Kerr DM, Harhen B, Okine BN, Egan LJ, Finn DP, Roche M, (2013). The monoacylglycerol lipase inhibitor JZL184 attenuates LPS-induced increases in cytokine expression in the rat frontal cortex and plasma: differential mechanisms of action. Br J Pharmacol 169: 808-819.
25. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
26. Loverme J, Russo R, La Rana G, Fu J, Farthing J, Mattace-Raso G, et al. (2006). Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha. J Pharmacol Exp Ther 319: 1051-1061.
27. Luongo L, De Novellis V, Gatta L, Palazzo E, Vita D, Guida F, et al. (2013). Role of metabotropic glutamate receptor 1 in the basolateral amygdala-driven prefrontal cortical deactivation in inflammatory pain in the rat. Neuropharmacology 66: 317-329.
28. Mackie K, Stella N, (2006). Cannabinoid receptors and endocannabinoids: evidence for new players. AAPS J 8: E298-E306.
29. Metz AE, Yau HJ, Centeno MV, Apkarian AV, Martina M, (2009). Morphological and functional reorganization of rat medial prefrontal cortex in neuropathic pain. Proc Natl Acad Sci U S A 106: 2423-2428.
30. Moreno S, Farioli-Vecchioli S, Ceru MP, (2004). Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. Neuroscience 123: 131-145. (Pubitemid 37518482)
31. Okine B, Norris L, Woodhams S, Burston J, Patel A, Alexander S, et al. (2012). Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system. Br J Pharmacol 167: 627-640.
32. Olango WM, Roche M, Ford GK, Harhen B, Finn DP, (2011). The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone. Br J Pharmacol 165: 2549-2560.
33. Paxinos GA, Watson C, (2006). The rat brain in stereotaxic coordinates. Elsevier, Inc.: London, UK.
34. Rea K, Roche M, Finn DP, (2013). Modulation of conditioned fear, fear-conditioned analgesia, and brain regional c-Fos expression following administration of muscimol into the rat basolateral amygdala. J Pain 12: 712-721.
35. Roche M, O'connor E, Diskin C, Finn DP, (2007). The effect of CB(1) receptor antagonism in the right basolateral amygdala on conditioned fear and associated analgesia in rats. Eur J Neurosci 26: 2643-2653. (Pubitemid 350050435)
36. Roche M, Johnston P, Mhuircheartaigh ON, Olango WM, Mackie K, Finn DP, (2009). Effects of intra-basolateral amygdala administration of rimonabant on nociceptive behaviour and neuronal activity in the presence or absence of contextual fear. Eur J Pain 14: 487-495.
37. Ryan RT, Bhardwaj SK, Tse YC, Srivastava LK, Wong TP, (2013). Opposing alterations in excitation and inhibition of layer 5 medial prefrontal cortex pyramidal neurons following neonatal ventral hippocampal lesion. Cereb Cortex 23: 1198-1207.
38. Sagar DR, Kendall DA, Chapman V, (2008). Inhibition of fatty acid amide hydrolase produces PPAR-alpha-mediated analgesia in a rat model of inflammatory pain. Br J Pharmacol 155: 1297-1306.
39. Shyu BC, Vogt BA, (2009). Short-term synaptic plasticity in the nociceptive thalamic-anterior cingulate pathway. Mol Pain 5: 51-70.
40. Starowicz K, Maione S, Cristino L, Palazzo E, Marabese I, Rossi F, de Novellis V, Di Marzo V, (2007). Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways. J Neurosci 27: 13739-13749. (Pubitemid 350278253)
41. Sun Y, Bennett A, (2007). Cannabinoids: a new group of agonists of PPARs. PPAR Res 2007: 1-7.
42. Sun Y, Alexander SP, Garle MJ, Gibson CL, Hewitt K, Murphy SP, et al. (2007). Cannabinoid activation of PPAR alpha; a novel neuroprotective mechanism. Br J Pharmacol 152: 734-743. (Pubitemid 350034991)
43. Taylor BK, Kriedt C, Nagalingam S, Dadia N, Badr M, (2005). Central administration of perfluorooctanoic acid inhibits cutaneous inflammation. Inflamm Res 54: 235-242. (Pubitemid 40853838)
44. Watson GS, Sufka KJ, Coderre TJ, (1997). Optimal scoring strategies and weights for the formalin test in rats. Pain 70: 53-58. (Pubitemid 27128297)
45. Xie YF, Huo FQ, Tang JS, (2009). Cerebral cortex modulation of pain. Acta Pharmacol Sin 30: 31-41.
46. Zaki J, Ochsner KN, Hanelin J, Wager TD, Mackey SC, (2007). Different circuits for different pain: patterns of functional connectivity reveal distinct networks for processing pain in self and others. Soc Neurosci 2: 276-291. (Pubitemid 47190217)